Experience NOCITA®

(bupivacaine liposome injectable suspension)

 

Now your veterinarian can help extend pain relief after your pet’s surgery.

All surgical procedures result in some degree of tissue trauma and pain. As pain can delay healing and return to function, veterinarians strive to minimize your pet’s discomfort following surgery.

NOCITA® is here to help. As an extended-release medication, it can help veterinarians better manage post-operative pain in dogs following cranial cruciate ligament surgery and cats undergoing elective onychectomy.

 

Nocita post-operative pain relief

Long-acting pain relief

The use of bupivacaine (a well-known local anesthetic) in a long-acting injectable formula has been proven to extend the duration of human post-operative analgesia from up to seven hours1 to as long as 72 hours. Similar results have been demonstrated in dogs and cats with the use of NOCITA®.

Ask your veterinarian

NOCITA® has been thoroughly tested in clinical studies. Ask your veterinarian for more details on how it could extend post-operative pain relief for your pet.

 

1Marcaine [package insert]. Lake Forest, IL: Hospira, Inc; 2014.

Are you a veterinary professional?

Learn more about how long-acting NOCITA® could provide the post-surgical pain relief for your patients.

“We began using Nocita on canine patients undergoing cranial cruciate ligament stabilization surgeries and have been very pleased with the results.  The product is intuitive to use and we have observed nothing but positive effects for our patients post-operatively.  Specifically, these patients appear to bear more significant weight immediately post-op than usually expected, require very little rescue analgesia, and are willing to eat early in the recovery period which has allowed easy transition to oral medications.  Nocita has quickly become standard protocol for analgesia on our canine cruciate ligament stabilization procedures.” 

Veterinary Surgeon

Milwaukee WI

DOG INDICATION: For single-dose infiltration into the surgical site to provide local post-operative analgesia for cranial cruciate ligament surgery in dogs.

IMPORTANT SAFETY INFORMATION: NOCITA® (bupivacaine liposome injectable suspension) is for local infiltration injection in dogs only. Do not use in dogs younger than 5 months of age, that are pregnant, lactating or intended for breeding. Do not administer by intravenous or intra‐arterial injection. Adverse reactions in dogs may include discharge from incision, incisional inflammation and vomiting. Avoid concurrent use with bupivacaine HCl, lidocaine or other amide local anesthetics. Please see the full Prescribing Information for more detail.

CAT INDICATION: For use as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats.

IMPORTANT SAFETY INFORMATION: NOCITA® (bupivacaine liposome injectable suspension) is for use as a peripheral nerve block in cats only. Do not use in cats younger than 5 months of age, that are pregnant, lactating, or intended for breeding. Do not administer by intravenous or intra‐arterial injection. Adverse reactions in cats may include elevated body temperature, infection or chewing/licking at the surgical site. Avoid concurrent use with bupivacaine HCl, lidocaine or other amide local anesthetics. Please see the full Prescribing Information for more detail.

Other therapeutics from Aratana

ENTYCE logo

Finally, appetite stimulation is in your control.

ENTYCE® (capromorelin oral solution) is the ONLY FDA-approved veterinary therapeutic designed to safely and effectively stimulate appetite in dogs. Administered orally once a day, ENTYCE is appropriate for treating inappetence caused by chronic and acute conditions.

VIEW WEBSITE

IMPORTANT SAFETY INFORMATION: ENTYCE® (capromorelin oral solution) is for use in dogs only. Do not use in breeding, pregnant or lactating dogs. Use with caution in dogs with hepatic dysfunction or renal insufficiency. Adverse reactions in dogs may include diarrhea, vomiting, polydipsia, and hypersalivation. Should not be used in dogs that have a hypersensitivity to capromorelin. Please see the full Prescribing Information for more detail.